[HTML][HTML] The role of biomarkers in the prediction of mortality in hospitalized patients for COVID-19

GA Cruz, H Pott-Junior, JP Gregorio 2… - …, 2022 - f1000research.com
Background: Despite the advances in the prognostic determinants in patients with COVID-
19, it is not well known which hospitalized patients may course with an adverse outcome …

Relationship between kalemia and intensive care unit admission or death in hospitalized COVID-19 patients: A cohort study

AF Guédon, A Delarue, N Mohamedi, A Roffé… - JMV-Journal de …, 2022 - Elsevier
Summary Background SARS-CoV-2 uses Angiotensin-Converting Enzyme 2 as a viral
gateway to the cell and could interact with the renin-angiotensin-aldosterone system. Other …

Modalités du traitement de la maladie veineuse thromboembolique du patient VIH par les anticoagulants oraux directs

NK Bentounes, Q Le Hingrat, B Planquette… - La Revue de Médecine …, 2023 - Elsevier
Résumé Malgré l'essor des antirétroviraux (ARV), l'infection par le virus de
l'immunodéficience humaine (VIH) reste un enjeu majeur de santé publique. Grâce à un …

[HTML][HTML] Prognostic capacity of D-dimer in predicting mortality in patients diagnosed with COVID-19: Capacidad pronóstica del dimero D en la predicción de …

J Alburqueque-Melgarejo… - Revista de la …, 2024 - revistas.urp.edu.pe
Abstract Introduction: SARS-CoV-2 infection can produce a hypercoagulable state and
increase the risk of developing thrombotic events. Several observational studies have …

C-Reactive Protein dan D-Dimer sebagai Prediktor Mortalitas Pasien COVID-19

RED Togas, ML Laihad, DC Lalenoh - Medical Scope Journal, 2023 - ejournal.unsrat.ac.id
Tingginya angka mortalitas pasien COVID-19 disebabkan oleh badai sitokin yang
meningkatkan perburukan kondisi pasien COVID-19 sehingga infeksi COVID-19 dikaitkan …

D-DIMER AS A PREDICTOR OF MORTALITY PROGNOSIS IN COVID-19 PATIENTS: SYSTEMATIC REVIEWS

D Suranti, RJ Sitorus, IA Liberty - Majalah Kedokteran …, 2024 - mks-fk.ejournal.unsri.ac.id
ABSTRACT Corona Virus Disease 19 or Covid-19 is an infectious disease caused by the
coronavirus officially named SARS-CoV-2. In December 2019, an outbreak of the COVID-19 …

[HTML][HTML] Different routine laboratory tests in assessment of COVID–19: A case–control study

I Adouani, T Bendaoud, H Belaaliat… - Journal of Acute …, 2022 - journals.lww.com
Objective: To identify helpful laboratory paprameters for the diagnosis and prognosis of
COVID-19. Methods: An observational retrospective study was conducted to analyze the …

[HTML][HTML] COVID-19 cardiological research in France: A nationwide perspective

R De Caterina - Archives of Cardiovascular Diseases, 2021 - ncbi.nlm.nih.gov
E-mail address: raffaele. decaterina@ unipi. it death toll has been highest for Italy (120,544),
with France following close (104,253). In terms of detected COVID-19 cases, France has the …

Predictors of Severe COVID-19 Outcome: A Meta-Analysis of Common Laboratory Biomarkers

N Anush, A Jasmin, PK Prabhakar, R Mathew… - ECS …, 2022 - iopscience.iop.org
COVID-19 is a multisystem sickness caused by the complex interaction of inflammatory,
immunological, and coagulative cascade. Risk assessment, choice of appropriate …

COVID-19 Associated Coagulopathy: D-Dimer and Fibrinolysis

ND Nielsen, D Swan, J Thachil - The Coagulation Labyrinth of Covid-19, 2021 - Springer
Fibrinolysis is the process of fibrin breakdown, catalyzed by plasmin. The terminal products
of fibrinolysis are the fibrin degradation products, of which D-dimer is the most commonly …